1. Home
  2. PCOR vs KRYS Comparison

PCOR vs KRYS Comparison

Compare PCOR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PCOR

Procore Technologies Inc.

HOLD

Current Price

$52.66

Market Cap

8.4B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$286.03

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCOR
KRYS
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
7.8B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
PCOR
KRYS
Price
$52.66
$286.03
Analyst Decision
Buy
Strong Buy
Analyst Count
16
11
Target Price
$74.19
$297.60
AVG Volume (30 Days)
2.4M
226.4K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
6.94
128.00
EPS
N/A
1.83
Revenue
$1,322,509,000.00
$389,130,000.00
Revenue This Year
$15.24
$38.74
Revenue Next Year
$12.99
$32.53
P/E Ratio
N/A
$155.12
Revenue Growth
14.83
33.94
52 Week Low
$46.08
$123.03
52 Week High
$82.32
$303.00

Technical Indicators

Market Signals
Indicator
PCOR
KRYS
Relative Strength Index (RSI) 44.13 63.63
Support Level $46.97 $254.53
Resistance Level $58.70 $293.60
Average True Range (ATR) 2.38 12.17
MACD 0.11 1.47
Stochastic Oscillator 8.17 66.94

Price Performance

Historical Comparison
PCOR
KRYS

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: